BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6446395)

  • 1. Microbiological studies on cefoperazone.
    Kayser FH
    Clin Ther; 1980; 3(Spec Issue):24-33. PubMed ID: 6446395
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
    Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.
    Wise R; Gillett AP; Andrews JM
    Clin Ther; 1980; 3(Spec Issue):149-55. PubMed ID: 6446391
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R; Waldvogel FA
    Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test.
    Thornsberry C; Baker CN; Barry AL; Jones RN
    Clin Ther; 1980; 3(Spec Issue):39-45. PubMed ID: 6446397
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteriological and pharmacological investigations with Garamycin (gentamicin).
    Nagy AE; Csatáry KN
    Acta Microbiol Acad Sci Hung; 1974; 21(3-4):289-91. PubMed ID: 4215292
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of cefoperazone against clinical isolates of Enterobacteriaceae, Pseudomonas and Staphylococcus.
    Olarte J
    Clin Ther; 1980; 3(Spec Issue):130-3. PubMed ID: 6446386
    [No Abstract]   [Full Text] [Related]  

  • 9. The Antibacterial activity in vitro and beta-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides.
    Seibert G; Limbert M; Winkler I; Dick T
    Infection; 1983; 11(5):275-9. PubMed ID: 6315595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological evaluation of cefoperazone, a new semisynthetic cephalosporin.
    Blandino G; Dubini F; Russo G; Cocuzza G
    Clin Ther; 1980; 3(Spec Issue):103-11. PubMed ID: 6446383
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro and in vivo microbiological evaluations of cefoperazone.
    Renzini G; Ravagnan G; Piccolomini R; Dainelli B; Comanducci A
    Clin Ther; 1980; 3(Spec Issue):139-44. PubMed ID: 6446388
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory evaluation of erythromycin in a general hospital.
    Watson KC
    S Afr Med J; 1969 May; 43(20):577-9. PubMed ID: 4389248
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1984 Jun; 7(1):13-9. PubMed ID: 6493580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of 523 blood culture isolates to 33 antibiotics.
    Ode B; Forsgren A; Walder M
    Scand J Infect Dis; 1984; 16(1):61-71. PubMed ID: 6559413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of RO 15-8074 and RO 19-5247.
    Valle T; Jalanko E; Scheinin L; Renkonen OV
    Eur J Clin Microbiol; 1987 Apr; 6(2):167-9. PubMed ID: 3109897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological studies on lomefloxacin--a new quinolone.
    Newsom SW; Rowland C
    J Chemother; 1989 Jul; 1(4 Suppl):168-9. PubMed ID: 16312354
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro action of moxalactam on hospital bacteria. Results of a multicenter survey].
    Duval J; Deforges L; Bergogne-Berezin E; Chabbert YA; Courtieu AL; Cluzel R; Dabernat H; Witchitz JL
    Sem Hop; 1983 Jun; 59(26):1949-52. PubMed ID: 6310784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cephalexin: microbiological effects and pharmacologic parameters in man.
    Meyers BR; Kaplan K; Weinstein L
    Clin Pharmacol Ther; 1969; 10(6):810-6. PubMed ID: 4900202
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro.
    Hamilton-Miller JM; Brumfitt W; Reynolds AV
    J Antimicrob Chemother; 1978 Sep; 4(5):437-44. PubMed ID: 308505
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifampicin: a new rifamycin. I. Bacteriological studies.
    Arioli V; Pallanza R; Furesz S; Carniti G
    Arzneimittelforschung; 1967 May; 17(5):523-9. PubMed ID: 4385644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.